Monday, September 22, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Ratings and Price Targets for Cushman Wakefield as of January 25 2024

Elaine Mendonca by Elaine Mendonca
January 25, 2024
in Breaking News
0
Real Estate Investment Trading online
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

In the past three months, a group of four analysts have shared their opinions on Cushman & Wakefield (NYSE:CWK), offering a range of perspectives from bullish to bearish. These recent ratings and 12-month price targets are as follows:

Recent Ratings:
– Bullish: 2
– Somewhat Bullish: 1
– Indifferent: 1
– Somewhat Bearish: 0
– Bearish: 0

12-Month Price Targets:
– Average Target: $11.00
– High Estimate: $12.00
– Low Estimate: $9.00

It is evident that there has been a decline of 2.91% from the prior average price target in the current average.

Let’s take a closer look at the key analyst actions:

– Patrick O’Shaughnessy of Raymond James has raised the rating to Strong Buy with a current price target of $12.00, up from $11.00.
– Andrew Rosivach of Wolfe Research has announced an Outperform rating with a price target of $12.00.
– Alex Kramm of UBS has lowered the rating to Neutral with a price target of $9.00, down from $11.00.
– Patrick O’Shaughnessy of Raymond James has lowered the rating to Strong Buy with a price target of $11.00, down from $12.00.

Overall, the average price target for Cushman & Wakefield stands at $11.00, with a high estimate of $12.00 and a low estimate of $9.00. This indicates a decline from the prior average price target. These recent actions and ratings reflect the changing sentiments and perceptions of financial experts towards Cushman & Wakefield as of January 25, 2024.

CWK Stock Shows Positive Performance on January 25, 2024: Investors Should Monitor Its Momentum

CWK stock had a positive performance on January 25, 2024, as it traded in the middle of its 52-week range and above its 200-day simple moving average. The price of CWK shares increased by $0.22 since the market last closed, representing a rise of 2.26%. On January 25, 2024, CWK stock opened at $10.22, which was $0.25 higher than its previous close. Overall, CWK stock had a strong performance on January 25, 2024. Investors should keep an eye on CWK stock and monitor its performance in the coming days to assess whether this positive momentum continues.

CWK Stock Performance on January 25, 2024: Analyzing Revenue, Net Income, and EPS Declines

CWK Stock Performances on January 25, 2024: A Closer Look at the Numbers

On January 25, 2024, the stock performance of CWK caught the attention of investors and analysts. The data revealed some interesting insights into the company’s financial performance. Let’s delve into the numbers and analyze CWK’s stock performance on that particular day.

Total revenue is a crucial metric that reflects a company’s overall financial health and growth. In the case of CWK, their total revenue for the past year stood at $10.11 billion. Comparing this figure to the previous year, CWK experienced a solid increase of 7.64%. However, when compared to the previous quarter, their total revenue dropped by 4.99%.

This decline in revenue from the previous quarter could be a cause for concern among investors. It is essential to dig deeper into the reasons behind this decrease to understand the underlying factors affecting CWK’s financial performance.

Moving on to net income, another crucial indicator of a company’s profitability, CWK reported a net income of $196.40 million for the past year. This figure represents a decline of 21.44% compared to the previous year. However, the most significant cause for concern arises when we analyze the net income for the previous quarter. CWK reported a net loss of -$33.90 million, indicating a staggering decrease of 764.71% compared to the previous quarter.

Such a substantial decline in net income within a single quarter raises red flags and demands further scrutiny. Investors and analysts must investigate the reasons behind this drastic decline in profitability to assess the company’s financial stability and growth potential.

Earnings per share (EPS) is yet another critical metric that provides insights into a company’s profitability on a per-share basis. CWK reported an EPS of $0.86 for the past year, representing a decrease of 21.96% compared to the previous year. However, the most concerning aspect is the EPS for the previous quarter, which stood at -$0.15. This figure indicates a drastic decline of 763.11% compared to the previous quarter.

The decline in EPS is a clear indication of the company’s struggle to generate profits and deliver value to its shareholders. Investors should pay close attention to the factors contributing to this decline and evaluate whether they are temporary or indicative of long-term challenges.

In conclusion, CWK’s stock performance on January 25, 2024, revealed a mixed bag of results. While their total revenue increased compared to the previous year, there was a notable decline compared to the previous quarter. The net income and EPS figures were even more concerning, with significant declines observed in both the yearly and quarterly comparisons. Investors and analysts should conduct further research to understand the reasons behind these declines and assess the company’s future prospects.

Tags: CWK
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Finance_ Chart up

Analyst Raises Price Target for BOK Financial

OHI stock news

Goldman Sachs Analyst Maintains Neutral Rating on ChargePoint Holdings

Insurance Stock Market Today

Decline in Health Insurers Stocks Humanas Disappointing Results and Industry Challenges

Recommended

Coherent Stock

Coherent Shares Tumble Despite Record Earnings as Guidance Disappoints

1 month ago
Genesco Stock

Genesco Shares Tumble Despite Strong Quarterly Performance

3 weeks ago
Finance_Investment (2)

Analyst at Cantor Fitzgerald Reiterates Neutral Rating and 128 Price Target for Sarepta Therapeutics NASDAQ SRPT

2 years ago
MMM stock news

The Power of Compounded Returns A Case Study of Union Pacific Stock

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

AAPL Adobe Alibaba Alphabet Amazon AMD AMZN Apple ASML BA BigBear.ai BioNTech Broadcom Coinbase Eli Lilly Fiserv Hims & Hers IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Opendoor Oracle Oxford Lane Capital Palantir PayPal Pepsi Red Cat Robinhood Rocket Lab USA Salesforce Strategy Tesla TSLA Unitedhealth Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Take-Two’s Strategic Moves Signal Confidence Ahead of Major Game Launch

Los Angeles-Based Lender Defies Industry Headwinds with Strong Dividend and Earnings

Institutional Investors Make Major Moves on Bristow Group

Is There Any Hope Left for Maravai LifeSciences Investors?

G-III Apparel Shares Face Significant Headwinds Following Disappointing Earnings

Nokia Finalizes Landmark $2.3 Billion Acquisition of Infinera

Trending

Stepan Stock
Analysis

Stepan Shares Face Market Pressure Despite Solid Operational Performance

by Robert Sasse
September 22, 2025
0

While Stepan Company delivered fundamentally sound operational results in its most recent quarter, its stock finds itself...

Paragon 28 Stock

Zimmer Biomet’s Billion-Dollar Acquisition Reshapes Orthopedic Landscape

September 22, 2025
MP Materials Stock

MP Materials Stock Surges Following Key Index Inclusion and Major Partnerships

September 22, 2025
Take-Two Stock

Take-Two’s Strategic Moves Signal Confidence Ahead of Major Game Launch

September 22, 2025
Preferred Bank of Los Angeles Stock

Los Angeles-Based Lender Defies Industry Headwinds with Strong Dividend and Earnings

September 22, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Stepan Shares Face Market Pressure Despite Solid Operational Performance
  • Zimmer Biomet’s Billion-Dollar Acquisition Reshapes Orthopedic Landscape
  • MP Materials Stock Surges Following Key Index Inclusion and Major Partnerships

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com